Cargando…
Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review
Alzheimer's disease (AD) is caused by several risk factors leading to dementia. It’s diagnosis usually depends on clinical presentation and certain biomarkers in the cerebrospinal fluid (CSF). The brain has a high content of cholesterol and the metabolism of cholesterol in the brain can be asso...
Autores principales: | Agarwal, Mehak, Khan, Safeera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797449/ https://www.ncbi.nlm.nih.gov/pubmed/33457117 http://dx.doi.org/10.7759/cureus.12008 |
Ejemplares similares
-
The Efficacy of Vitamin D Supplementation in Patients With Alzheimer's Disease in Preventing Cognitive Decline: A Systematic Review
por: Chakkera, Mohana, et al.
Publicado: (2022) -
The Effect of Statin Therapy on Inflammatory Biomarkers: A Systematic Review
por: Proute, Matthew C, et al.
Publicado: (2021) -
Prospect of Alpha-Synuclein (A-Syn) Isolation From Saliva as a Promising Diagnostic Biomarker Alternative in Parkinson’s Disease (PD): A Systematic Review
por: Muddaloor, Pratyusha, et al.
Publicado: (2022) -
Comparing the Diagnostic Accuracy of Procalcitonin and C-Reactive Protein in Neonatal Sepsis: A Systematic Review
por: Anugu, NagaSpurthy Reddy, et al.
Publicado: (2021) -
Is Deep Brain Stimulation Associated With Detrimental Effects on Cognitive Functions in Patients of Parkinson's Disease? A Systematic Review
por: Maheshwary, Ankush, et al.
Publicado: (2020)